BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6306373)

  • 1. Effect of glucocorticoids on alpha-2 adrenoceptors in vas deferens of reserpinized rat in organ culture.
    Maeda H; Watanabe Y; Lai RT; Yoshida H
    Life Sci; 1983 Jul; 33(1):39-46. PubMed ID: 6306373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3H-Prazosin binds specifically to 'alpha 1'-adrenoceptors in rat brain.
    Miach PJ; Dausse JP; Cardot A; Meyer P
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):23-6. PubMed ID: 6248797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reserpine and sympathetic denervation cause an increase of postsynaptic alpha 2-adrenoceptors.
    Watanabe Y; Lai RT; Maeda H; Yoshida H
    Eur J Pharmacol; 1982 May; 80(1):105-8. PubMed ID: 6284526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies with (imidazolinyl-2)-2-benzodioxane-1-4 ((+/-)-170 150), a new potent alpha 2-adrenoceptor blocking agent.
    Dabiré H; Dausse JP; Mouillé P; Schmitt H; Meyer P
    Eur J Pharmacol; 1982 Dec; 86(1):87-90. PubMed ID: 6130957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of [3H]guanfacine to rat brain alpha-adrenoceptors. Comparison with [3H]clonidine.
    Timmermans PB; Schoop AM; van Zwieten PA
    Biochem Pharmacol; 1982 Mar; 31(6):899-905. PubMed ID: 6282284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the [3H]-yohimbine binding on rat brain alpha2-adrenoceptors.
    Rouot B; Quennedey MC; Schwartz J
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):253-9. PubMed ID: 6300700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between 2-chloroadenosine and alpha-adrenoceptors in rat vas deferens.
    Lai RT; Watanabe Y; Kamino Y; Yoshida H
    Life Sci; 1984 Jan; 34(5):409-18. PubMed ID: 6319943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist/agonist-preferring alpha-adrenoceptors or alpha 1/alpha 2-adrenoceptors?
    Tanaka T; Starke K
    Eur J Pharmacol; 1980 May; 63(2-3):191-4. PubMed ID: 6103816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [3H]prazosin and [3H]p-aminoclonidine to alpha-adrenoceptors in rat spinal cord.
    Simmons RM; Jones DJ
    Brain Res; 1988 Apr; 445(2):338-49. PubMed ID: 2836025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens.
    Sallés J; Badia A
    Br J Pharmacol; 1991 Feb; 102(2):439-45. PubMed ID: 1673073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of 3H-guanfacine to alpha 2-adrenoceptors in rat brain. Comparison with 3H-clonidine.
    Dausse JP; Cardot A; Meyer P
    J Pharmacol; 1983; 14(1):35-46. PubMed ID: 6300560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenoxybenzamine partially inhibits alpha 2-adrenoceptors without affecting their presynaptic function.
    McKernan RM; Campbell IC
    Neuropharmacology; 1986 Jan; 25(1):47-52. PubMed ID: 2869437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postsynaptic effects of alpha agonists on adrenoceptors of the reserpinized rat vas deferens.
    Breschi MC; Martinotti E; Ducci M; Fantoni B
    Pharmacol Res Commun; 1987 Jun; 19(6):415-27. PubMed ID: 2889223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]clonidine and [3H]yohimbine binding to solubilized alpha 2-adrenoceptors from rat cerebral cortex.
    Kitamura Y; Tanaka H; Nomura Y
    Eur J Pharmacol; 1986 Apr; 123(2):263-70. PubMed ID: 3011462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]prazosin and [3H]clonidine binding to alpha-adrenoceptors in membranes prepared from regions of rat kidney.
    McPherson GA; Summers RJ
    J Pharm Pharmacol; 1981 Mar; 33(3):189-91. PubMed ID: 6116768
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of alpha 2-adrenergic receptors of rat vas deferens by adenosine receptors.
    Watanabe Y; Yoshida H
    Adv Exp Med Biol; 1984; 175():133-43. PubMed ID: 6093450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
    Perrone MH; Hamel LT; Ferrari RA; Haubrich DR
    J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.